WHITCHURCH-STOUFFVILLE, CANADA (PRWEB) JANUARY 15, 2016
Saringer Life Science Technologies, a medical device company headquartered in Toronto Canada, has announced a next-generation model of the Venowave mobile compression device- the Venowave2.
The first generation Venowave is the first and only mobile compression device to use patented peristaltic technology for continuous blood movement. The lightweight, compact design offers portability and increased patient compliance for use post-discharge for prevention of venous thromboembolism (VTE).
Full Article Here: www.prweb.com
The post Whitchurch-Stouffville based Saringer Life Science Technologies Introduces Next Generation Mobile Compression Device and US Distribution Partner appeared first on Toronto Area's Tech Hub.